Tower Research Capital LLC (Trc) Catalyst Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.33 - $0.65 $901 - $1,775	2,732 Added 212.61%	4,017 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.2 - $0.35 $18 - $32	-92 Reduced 6.68%	1,285 $0
Q1 2023 May 09, 2023	SELL	$0.19 - $0.64 $3 - $10	-17 Reduced 1.22%	1,377 $0
Q4 2022 Feb 10, 2023	SELL	$0.49 - $0.57 $334 - $388	-682 Reduced 32.85%	1,394 $1,000
Q3 2022 Nov 10, 2022	BUY	$0.49 - $1.95 $437 - $1,739	892 Added 75.34%	2,076 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.36 - $1.78 $716 - $3,543	-1,991 Reduced 62.71%	1,184 $2,000
Q1 2022 May 12, 2022	BUY	$0.51 - $1.0 $1,619 - $3,175	3,175 New	3,175 $2,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $11,266 - $14,646	-2,748 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $2,514 - $3,646	510 Added 22.79%	2,748 $14,000
Q4 2020 Feb 16, 2021	SELL	$4.55 - $7.29 $73,200 - $117,281	-16,088 Reduced 87.79%	2,238 $14,000
Q3 2020 Nov 16, 2020	BUY	$4.22 - $6.04 $29,556 - $42,304	7,004 Added 61.86%	18,326 $79,000
Q2 2020 Aug 13, 2020	BUY	$3.76 - $8.01 $36,362 - $77,464	9,671 Added 585.77%	11,322 $66,000
Q1 2020 May 15, 2020	SELL	$3.5 - $8.51 $3,629 - $8,824	-1,037 Reduced 38.58%	1,651 $8,000
Q4 2019 Feb 07, 2020	BUY	$4.52 - $7.91 $11,765 - $20,589	2,603 Added 3062.35%	2,688 $18,000
Q3 2019 Nov 05, 2019	SELL	$4.91 - $9.31 $19,404 - $36,793	-3,952 Reduced 97.89%	85 $0
Q2 2019 Aug 13, 2019	BUY	$7.08 - $10.6 $27,385 - $41,000	3,868 Added 2288.76%	4,037 $29,000
Q1 2019 May 14, 2019	BUY	$7.67 - $9.96 $1,296 - $1,683	169 New	169 $1,000
Q4 2018 Feb 14, 2019	SELL	$6.59 - $11.28 $6,135 - $10,501	-931 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$9.35 - $12.44 $5,207 - $6,929	557 Added 148.93%	931 $10,000
Q2 2018 Aug 15, 2018	BUY	$9.11 - $28.88 $3,407 - $10,801	374 New	374 $4,000

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account